# Optieum Biotechnologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/optieum-biotechnologies

- Industry: Biotechnology
- Headquarters: Japan
- Website: www.optieumbio.com
- Total disclosed funding: $8.5M
- Latest round: Series A (Jan 14, 2025)
- Investors on record: 7

## About

Founded in 2020 and based in Toon, Japan, Optieum Biotechnologies Inc operates as a biotechnology company that uses the potential of T-cells for developing treatments for cancer and other diseases. In April 2026, Optieum Biotechnologies Inc raised an undisclosed amount in venture funding from Vision Incubate. The firm as of January 2025, is led by its President and CEO, Shun Nishioka.

Optieum Biotechnologies specializes in advanced biopharmaceutical solutions, primarily focusing on optimizing CAR-T (Chimeric Antigen Receptor T-cell) therapies and addressing the critical unmet needs in oncology. Their core offerings enhance immune responses against various cancers, providing advancements in personalized medicine. Optieum's products are utilized in clinical trials across North America and Europe, catering to healthcare providers, research institutions, and biopharmaceutical companies seeking cancer treatment options. 

Optieum Biotechnologies generates revenue primarily through collaborations, licensing agreements, and clinical trial partnerships with pharmaceutical companies and healthcare institutions.

The company will use the April 2026 funding to accelerate clinical trial preparation for its lead CAR-T pipeline.

## Funding rounds

- Series A, Jan 14, 2025, $8.5M — ANRI, UntroD Capital, Iyogin Capital, Keio Innovation Initiative, Zeon Corporation, Saisei Ventures, Kobe University Capital

## Investors

- ANRI (https://capitalatlas.ai/funds/anri) — Series A
- UntroD Capital — Series A
- Iyogin Capital (https://capitalatlas.ai/funds/iyogin-capital) — Series A
- Keio Innovation Initiative (https://capitalatlas.ai/funds/keio-innovation-initiative) — Series A
- Zeon Corporation — Series A
- Saisei Ventures (https://capitalatlas.ai/funds/saisei-ventures) — Series A
- Kobe University Capital (https://capitalatlas.ai/funds/kobe-university-capital) — Series A